Skip to main content

Table 2 Assessment Schedule

From: Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

Assessment

Screening

Baseline

Week 2

Week 4

Week 6

Week 8

Week 10

Week 12

Ad hoc

Medical Confirmation of Eligibility, SCID-5

x

        

Clinical Bloodwork

x

        

Randomization

x

x

       

HRSD-17

x

x

x

 

x

  

x

 

CGI

 

x

x

 

x

  

x

 

GAD-7

 

x

x

 

x

  

x

 

WHOQOL-BREF

 

x

x

 

x

  

x

 

Minocycline dispensed

 

x

x

 

x

    

TAU/Concomitant medication

 

x

x

 

x

  

x

 

Adverse Event Checks

 

x

x

 

x

  

x

x

Physical health measures

 

x

       

Biomarkers (CRP, cytokines)

 

x

     

x

 

Telephone contact

   

x

 

x

x

x

x